PortfoliosLab logoPortfoliosLab logo
DDS vs. NUKZ
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

DDS vs. NUKZ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Dillard's, Inc. (DDS) and Range Nuclear Renaissance ETF (NUKZ). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, DDS achieves a 0.66% return, which is significantly lower than NUKZ's 7.57% return.


DDS

1D
-0.70%
1M
14.47%
YTD
0.66%
6M
-10.45%
1Y
58.44%
3Y*
27.17%
5Y*
35.97%
10Y*
30.59%

NUKZ

1D
1.59%
1M
-5.07%
YTD
7.57%
6M
4.81%
1Y
27.91%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

DDS vs. NUKZ - Yearly Performance Comparison


2026 (YTD)20252024
DDS
Dillard's, Inc.
0.66%46.81%17.78%
NUKZ
Range Nuclear Renaissance ETF
7.57%56.57%60.11%

Correlation

The correlation between DDS and NUKZ is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.21

Correlation (All Time)
Calculated using the full available price history since Jan 24, 2024

0.26

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

DDS vs. NUKZ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DDS
DDS Risk / Return Rank: 8080
Overall Rank
DDS Sharpe Ratio Rank: 8383
Sharpe Ratio Rank
DDS Sortino Ratio Rank: 7878
Sortino Ratio Rank
DDS Omega Ratio Rank: 7777
Omega Ratio Rank
DDS Calmar Ratio Rank: 8080
Calmar Ratio Rank
DDS Martin Ratio Rank: 7979
Martin Ratio Rank

NUKZ
NUKZ Risk / Return Rank: 3131
Overall Rank
NUKZ Sharpe Ratio Rank: 2929
Sharpe Ratio Rank
NUKZ Sortino Ratio Rank: 3030
Sortino Ratio Rank
NUKZ Omega Ratio Rank: 2727
Omega Ratio Rank
NUKZ Calmar Ratio Rank: 3939
Calmar Ratio Rank
NUKZ Martin Ratio Rank: 3232
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DDS vs. NUKZ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Dillard's, Inc. (DDS) and Range Nuclear Renaissance ETF (NUKZ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


DDSNUKZDifference
Sharpe ratioReturn per unit of total volatility

+0.56

Sortino ratioReturn per unit of downside risk

+0.64

Omega ratioGain probability vs. loss probability

1.27

1.17

+0.10

Calmar ratioReturn relative to maximum drawdown

2.42

1.70

+0.72

Martin ratioReturn relative to average drawdown

5.60

4.11

+1.48

DDS vs. NUKZ - Sharpe Ratio Comparison

The current DDS Sharpe Ratio is 1.48, which is higher than the NUKZ Sharpe Ratio of 0.92. The chart below compares the historical Sharpe Ratios of DDS and NUKZ, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

DDS vs. NUKZ - Drawdown Comparison

The maximum DDS drawdown since its inception was -93.62%, which is greater than NUKZ's maximum drawdown of -33.03%. Use the drawdown chart below to compare losses from any high point for DDS and NUKZ.


Loading charts...

Drawdown Indicators


DDSNUKZDifference

Max Drawdown

Largest peak-to-trough decline

-93.62%

-33.03%

-60.59%

Max Drawdown (1Y)

Largest decline over 1 year

-24.27%

-16.51%

-7.76%

Max Drawdown (3Y)

Largest decline over 3 years

-42.02%

Max Drawdown (5Y)

Largest decline over 5 years

-49.71%

Max Drawdown (10Y)

Largest decline over 10 years

-76.57%

Current Drawdown

Current decline from peak

-12.84%

-10.39%

-2.45%

Average Drawdown

Average peak-to-trough decline

-35.61%

-6.06%

-29.55%

Ulcer Index

Depth and duration of drawdowns from previous peaks

10.47%

6.80%

+3.67%

Volatility

DDS vs. NUKZ - Volatility Comparison

The current volatility for Dillard's, Inc. (DDS) is 10.15%, while Range Nuclear Renaissance ETF (NUKZ) has a volatility of 11.24%. This indicates that DDS experiences smaller price fluctuations and is considered to be less risky than NUKZ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


DDSNUKZDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.15%

11.24%

-1.09%

Volatility (6M)

Calculated over the trailing 6-month period

27.84%

23.34%

+4.50%

Volatility (1Y)

Calculated over the trailing 1-year period

39.57%

30.46%

+9.11%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

50.28%

32.94%

+17.34%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

59.53%

32.94%

+26.59%

Dividends

DDS vs. NUKZ - Dividend Comparison

DDS's dividend yield for the trailing twelve months is around 5.11%, more than NUKZ's 0.85% yield.


PositionTTM20252024202320222021202020192018201720162015
DDS
Dillard's, Inc.
5.11%5.13%6.02%5.18%4.89%6.41%0.95%0.68%0.66%0.57%0.45%0.40%
NUKZ
Range Nuclear Renaissance ETF
0.85%0.91%0.09%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


DDS and NUKZ have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

NUKZ has higher volatility (11.24%) compared to DDS (10.15%). In terms of maximum drawdown, DDS dropped -93.62% vs NUKZ's -33.03%.

DDS currently has the higher Sharpe Ratio (1.48 vs 0.92), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for DDS and NUKZ

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer